Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.
Abstract
CONTEXT: Media and scientific reports have indicated an increase in recreational use
of Salvia divinorum. Epidemiological data are lacking on the trends, prevalence, and
correlates of S. divinorum use in large representative samples, as well as the extent
of substance use and mental health problems among S. divinorum users. OBJECTIVE: To
examine the national trend in prevalence of S. divinorum use and to identify sociodemographic,
behavioral, mental health, and substance-use profiles of recent (past-year) and former
users of S. divinorum. DESIGN: Analyses of public-use data files from the 2006-2008
United States National Surveys on Drug Use and Health (N = 166,453). SETTING: Noninstitutionalized
individuals aged 12 years or older were interviewed in their places of residence.
MAIN MEASURES: Substance use, S. divinorum, self-reported substance use disorders,
criminality, depression, and mental health treatment were assessed by standardized
survey questions administered by the audio computer-assisted self-interviewing method.
RESULTS: Among survey respondents, lifetime prevalence of S. divinorum use had increased
from 0.7% in 2006 to 1.3% in 2008 (an 83% increase). S. divinorum use was associated
with ages 18-25 years, male gender, white or multiple race, residence of large metropolitan
areas, arrests for criminal activities, and depression. S. divinorum use was particularly
common among recent drug users, including users of lysergic acid diethylamide (53.7%),
ecstasy (30.1%), heroin (24.2%), phencyclidine (22.4%), and cocaine (17.5%). Adjusted
multinomial logistic analyses indicated polydrug use as the strongest determinant
for recent and former S. divinorum use. An estimated 43.0% of past-year S. divinorum
users and 28.9% of former S. divinorum users had an illicit or nonmedical drug-use
disorder compared with 2.5% of nonusers. Adjusted logistic regression analyses showed
that recent and former S. divinorum users had greater odds of having past-year depression
and a substance-use disorder (alcohol or drugs) than past-year alcohol or drug users
who did not use S. divinorum. CONCLUSION: S. divinorum use is prevalent among recent
or active drug users who have used other hallucinogens or stimulants. The high prevalence
of substance use disorders among recent S. divinorum users emphasizes the need to
study health risks of drug interactions.
Type
Journal articlePermalink
https://hdl.handle.net/10161/11011Published Version (Please cite this version)
10.2147/SAR.S17192Publication Info
Wu, Li-Tzy; Woody, George E; Yang, Chongming; Li, Jih-Heng; & Blazer, Dan G (2011). Recent national trends in Salvia divinorum use and substance-use disorders among recent
and former Salvia divinorum users compared with nonusers. Subst Abuse Rehabil, 2011(2). pp. 53-68. 10.2147/SAR.S17192. Retrieved from https://hdl.handle.net/10161/11011.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Daniel German Blazer
J. P. Gibbons Distinguished Professor Emeritus of Psychiatry
I am currently semi-retired. Most of my recent work has been focused on roles with
the National Academy of Medicine (former Institute of Medicine). I have chaired three
committees during the past four years, one on the mental health and substance use workforce,
one on cognitive aging, and one on hearing loss in adults. I currently also chair
the Board on the Health of Select Populations for the National Academies. In the past
I have been PI on a number of research
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info